Drug Firms Focus on Advanced Melanoma

Bristol-Myers, Roche and Merck are each working on a potential blockbuster “immunotherapy” drug that would use the body’s immune system to fight advanced melanoma. Astra has an earlier-stage candidate.

Leave a Reply

Your email address will not be published. Required fields are marked *